The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. - Wikidata - wikimedia - TriplyDB

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.

http://www.wikidata.org/entity/Q38208428

about

Guideline of Chronic Urticaria Beyond The Effectiveness and Safety of Acupuncture for Patients with Chronic Urticaria: A Systematic Review Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine Advances in Understanding and Managing Chronic Urticaria Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy Profile of omalizumab in the treatment of chronic spontaneous urticaria Acupuncture for patients with chronic urticaria: a systematic review protocol Immunoglobulin E in irritable bowel syndrome: another target for treatment? A case report and literature review Immunological events in chronic spontaneous urticaria Management of urticaria: not too complicated, not too simple Chronic urticaria in adults: state-of-the-art in the new millennium Approaches to the diagnosis and management of chronic urticaria in children Treatment of Refractory Chronic Urticaria Aquagenic urticaria: diagnostic and management challenges Bradykinin: Inflammatory Product of the Coagulation System Questions and answers in chronic urticaria: where do we stand and where do we go?Heat urticaria: a revision of published cases with an update on classification and management.Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases Sense of coherence as a protective factor in chronic urticaria.Increased cis-to-trans urocanic acid ratio in the skin of chronic spontaneous urticaria patients.Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador.Increased Risk of Chronic Spontaneous Urticaria in Patients With Autoimmune Thyroid Diseases: A Nationwide, Population-based Study.A rapid method of detecting autoantibody against FcεRIα for chronic spontaneous urticaria.In the memory of Professor Felicidad Cua-Lim.Chronic spontaneous urticaria and internal parasites--a systematic review.Omalizumab in children.The care pathway for children with urticaria, angioedema, mastocytosis Clinical similarities among bradykinin-mediated and mast cell-mediated subtypes of non-hereditary angioedema: a retrospective study.Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies.Insights and advances in chronic urticaria: a Canadian perspective.Treatment of solar urticaria using antihistamine and leukotriene receptor antagonist combinations tailored to disease severity.Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk.Retrospective case note review of chronic spontaneous urticaria outcomes and adverse effects in patients treated with omalizumab or ciclosporin in UK secondary care.ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria.Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria.Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature.A study of treatment adherence and quality of life among adults with chronic urticaria in Singapore.The Impact of Chronic Urticaria from the Patient's Perspective: A Survey in Five European Countries.

P2860

Q26743369-0C3E3622-169D-4DF8-89DE-4E0E3DCF2462 Q26744555-9F680C64-13C3-4BFD-AB9D-C2601AD6FA2F Q26750723-924E8C35-B8C6-47DF-B0EF-C4E57DB5312A Q26767461-7DFCE00E-694B-4418-B8C1-AC0A424B174A Q26769045-B45E7DB0-8E3D-4C3A-A903-10F041AC832C Q26777088-CD859474-14AC-4BE0-94D6-E5C0E0F250D4 Q26783158-C122246A-C1E4-4C0D-AB0A-838E505C375E Q26785661-3F44D3DE-7256-474A-AC64-90A116A870A2 Q26795564-67BDD55F-8B60-44C3-8EAC-5C82604CFF80 Q26796886-7B5A044D-9572-4486-A6FE-CD5F00164A6E Q26828373-9C8DA245-C3A5-4E18-90FE-AC1026E0091A Q26849258-1BB08D3D-B70D-4D9A-AA3A-CBA99AD710D8 Q26852686-A86991C8-8D31-4EE6-9CBA-E43A27D4854C Q26865314-3DFD8F58-E347-4E76-9E08-B6050A969393 Q28069329-1F1E48D7-A095-46E9-AD76-DCE3B324722D Q28072738-57068DE5-4B87-4359-B1B9-8052B95E96A3 Q30249703-A7334CEC-B126-46BB-B6B9-6E778DDC947B Q33166940-6BC1ED04-894B-45D3-B341-4F3EB0372F54 Q33588223-2929D41E-61E8-4C27-B906-D15BA74C6A87 Q33625914-5C9E915B-5B9E-4565-94F0-AF510C8FD2D2 Q33645883-F6DA8F7C-DE7E-4DB4-B372-D894C5A89795 Q33683786-430E8962-BA77-4E89-A0E3-D653FFAA0E82 Q33716563-35411D97-5167-4AF9-8257-0A2F703FC0C7 Q33734366-CE193E50-E561-4164-8771-07F0345B963A Q34343584-005A45E6-AB37-442D-86DF-7829714BF0BC Q34432060-009DF09F-AC72-4CE9-A946-DAE60456A31C Q34504507-E7B3931B-07B0-4B59-8AEA-2A37FC4C7600 Q34604574-7D958823-265E-475A-A56B-CD04FC9AEF89 Q35036770-AA55ED90-DF66-49CB-BB72-36132B18F351 Q35060529-9C4B7C2B-E76B-499A-955B-0F561301EFE6 Q35078702-07999042-4FDC-42A6-8A8D-CE2CBAD3B5B2 Q35108534-EDF12F28-A5A7-40A6-8F6A-146938074538 Q35656087-7C3FE796-BD53-4525-958E-978267AA26AE Q35658142-BCEB1FDE-A363-4F83-B0D2-F6C082A3A96B Q35865960-EF0D8318-94EC-4154-9F3C-F2D442710C03 Q35961702-73C901FD-098D-47C1-A5CA-B5E375D658C7 Q36016733-C50E3F26-EAAD-4C4E-BC2F-AF9A2E0D6886 Q36082959-842EF6EA-DA33-418F-B420-3CA03370B959 Q36241656-0CC6F6B0-26B3-4DE0-BBF1-2A7051E4BFC1 Q36327840-2CC5B6FA-C21D-4E48-8F4B-6BE6A6E2E60A

P2860

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.

http://www.wikidata.org/entity/Q38208428

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The EAACI/GA(2) LEN/EDF/WAO Gu ...... the 2013 revision and update.

@en

type

label

The EAACI/GA(2) LEN/EDF/WAO Gu ...... the 2013 revision and update.

@en

prefLabel

The EAACI/GA(2) LEN/EDF/WAO Gu ...... the 2013 revision and update.

@en

P1433

Q38208428-39B6CD28-F9D1-42D1-AB46-F48F1EB6AD87

P1476

Q38208428-86D50EDC-2E03-48FD-8F00-80C169FC3F68

P2093

Q38208428-027F5FE9-EAC5-4870-B5EF-CDE475055531

Q38208428-119DB7F7-E099-4D5B-B720-84E5EA0356CE

Q38208428-15C2FBE8-4FC2-4937-B88C-E6AE376FE8C6

Q38208428-21B78963-02C7-4D7A-BBFE-372DF4CD1FB5

Q38208428-2F13CBAA-FBFB-40D4-A8C3-1F40F8356D15

Q38208428-348A7A32-6963-4858-9990-25DC4241F1E1

Q38208428-3A1187B5-23B7-4AC3-B435-E16FDE3F1100

Q38208428-3A3C8B1D-D774-49B9-8DA9-F12BBB8D2A03

Q38208428-3A79A907-CDC9-4FD0-95CD-FC71262BF444

Q38208428-4085F85A-FD6C-4AD4-A087-8C1B74A263D2

P2860

Q38208428-02623547-D181-4959-8649-4A0912241A37

Q38208428-07A27894-944F-4FF3-8E7E-BF87DB6D3685

Q38208428-07F491D9-3432-4698-BFF8-19734149671E

Q38208428-086F6BC8-6FD2-45EC-A369-80754E20BC81

Q38208428-0D0D4EF3-4295-41E8-88C7-75C85C91254C

Q38208428-0F131756-F1AB-46A8-B7D1-18C8B50D8407

Q38208428-0F8EC307-68D9-40D4-B632-BC99247FB07C

Q38208428-12F10F1A-874A-495E-953D-21AD7BCE1EA6

Q38208428-160762A0-1E86-48EB-84A9-CD2315DE2368

Q38208428-18BBDA85-1007-4DB5-BA52-7DCE32936ED3

P304

Q38208428-2A336A08-6774-4E28-A617-E426CFB29177

P31

Q38208428-DDA16979-35E5-44DD-BA9C-CCE2DA0F8E03

P356

Q38208428-5373D64D-8A72-4C0D-B3B8-554D5C16CE7D

P433

Q38208428-7FB6AF33-D34C-42FA-8873-EA7923B5A0A7

P478

Q38208428-DA25D710-ED6D-4E09-85CF-B7599C2D8C09

P50

Q38208428-195D8258-B908-4D67-88FD-3475FE0D2252

Q38208428-199A987C-ECDF-490C-A421-0D7FE284C38C

Q38208428-2F7BC9B8-D66A-4795-86DF-C95A9E4C5516

Q38208428-B3944C1E-D4C4-4C1D-893D-1C5A28D748AE

Q38208428-BE4862E2-097A-46BA-8F04-819A7CAB5608

Q38208428-DD9494E2-82D3-4A67-9F62-6F7EF9C61D56

P577

Q38208428-638B33B3-7233-47E9-B4EE-1E75C3478061

P5875

Q38208428-FDC72CF2-4784-4F0C-8965-9339CFB2D165

P698

Q38208428-F306E0F6-BAF9-48BF-A2EC-3A815C81752F

P921

Q38208428-ee7b55e2-dd16-4576-8942-1da5e18a4c93

P356

P1433

P1476

The EAACI/GA(2) LEN/EDF/WAO Gu ...... the 2013 revision and update.

@en

P2093

A Giménez-Arnau

http://www.w3.org/2001/XMLSchema#string

A H Abdul Latiff

http://www.w3.org/2001/XMLSchema#string

A Kaplan

http://www.w3.org/2001/XMLSchema#string

A Kapp

http://www.w3.org/2001/XMLSchema#string

A Nast

http://www.w3.org/2001/XMLSchema#string

C Grattan

http://www.w3.org/2001/XMLSchema#string

European Academy of Allergy and Clinical Immunology

http://www.w3.org/2001/XMLSchema#string

European Dermatology Forum

http://www.w3.org/2001/XMLSchema#string

F E R Simons

http://www.w3.org/2001/XMLSchema#string

G A Vena

http://www.w3.org/2001/XMLSchema#string

P2860

What is "quality of evidence" and why is it important to clinicians?

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

The extent and nature of disability in different urticarial conditions

Sera from patients with multiple drug allergy syndrome contain circulating histamine-releasing factors

Drug-induced urticarias

Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy

Urticaria and infections.

IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria?

Chronic urticaria in childhood.

Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity.

P304

868-887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ALL.12313

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Torsten Zuberbier

Margarida Gonçalo

Carsten Bindslev-Jensen

Giorgio Walter Canonica

P577

2014-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262015711

http://www.w3.org/2001/XMLSchema#string

P698

24785199

http://www.w3.org/2001/XMLSchema#string

P921